Premium
Genome‐Wide Association Studies of Down Syndrome Associated Congenital Heart Defects Suggests a Genetically Heterogeneous Risk for CHD in DS
Author(s) -
Feldman Elizabeth R.,
Li Yunqi,
Cutler David J.,
Rosser Tracie C.,
Wechsler Stephanie B.,
Sanclemente Lauren,
Rachubinski Angela L.,
Elliott Natalina,
Vyas Paresh,
Roberts Irene,
Rabin Karen R.,
Wagner Michael,
Gelb Bruce D.,
Espinosa Joaquin M.,
Lupo Philip J.,
Smith Adam J.,
Sherman Stephanie L.,
LeslieClarkson Elizabeth J.
Publication year - 2025
Publication title -
genetic epidemiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.301
H-Index - 98
eISSN - 1098-2272
pISSN - 0741-0395
DOI - 10.1002/gepi.70010
ABSTRACT Congenital heart defects (CHDs) are the most common structural birth defect and are present in 40%–50% of children born with Down syndrome (DS). To characterize the genetic architecture of DS‐associated CHD, we sequenced genomes of a multiethnic group of children with DS and a CHD ( n = 886: atrioventricular septal defects (AVSD), n = 438; atrial septal defects (ASD), n = 122; ventricular septal defects (VSD), n = 170; other types of CHD, n = 156) and DS with a structurally normal heart (DS + NH, n = 572). We performed four genome‐wide association study (GWAS) for common variants (MAF > 0.05) comparing DS with CHD, stratified by CHD‐subtype, to DS + NH controls. Although no SNP achieved genome‐wide significance, multiple loci in each analysis achieved suggestive significance ( p < 2 × 10 −6 ). Of these, the 1p35.1 locus (near RBBP4 ) was specifically associated with ASD risk, and the 5q35.2 locus (near MSX2 ) was associated with any type of CHD. Each of the suggestive loci contained one or more plausible candidate genes expressed in the developing heart. While no SNP replicated ( p < 2 × 10 −6 ) in an independent cohort of DS + CHD (DS + CHD: n = 229; DS + NH: n = 197), most SNPs that were suggestive in our GWASs remained suggestive when meta‐analyzed with the GWASs from the replication cohort. These results build on previous work to identify genetic modifiers of DS‐associated CHD.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom